Alerts will be sent to your verified email
Verify EmailZENITHHE
Zenith Health Care
|
Chemo Pharma Labs
|
Shamrock Indl. Co
|
|
---|---|---|---|
Operational Metrics
|
|||
Financials
|
|||
5 yr Average ROE
|
4.69 % | -4.51 % | -8.9 % |
5yr average Equity Multiplier
|
1.34 | 1.01 | 1.02 |
5yr Average Asset Turnover Ratio
|
1.59 | 0.0 | 0.0 |
5yr Avg Net Profit Margin
|
2.26 % | 0.0 | 0.0 |
Price to Book
|
2.84 | 1.52 | 11.85 |
P/E
|
0.0 | 0.0 | 0.0 |
5yr Avg Cash Conversion Cycle
|
77.41 Days | 0.0 | 0.0 |
Inventory Days
|
70.5 Days | 0.0 | 0.0 |
Days Receivable
|
54.46 Days | 0.0 | 0.0 |
Days Payable
|
55.38 Days | 0.0 | 68.55 Days |
5yr Average Interest Coverage Ratio
|
47.8 | 794.39 | 0.0 |
5yr Avg ROCE
|
6.61 % | -3.17 % | -8.89 % |
5yr Avg Operating Profit Margin
|
2.14 % | 0.0 | 0.0 |
5 yr average Debt to Equity
|
0.0 | 0.01 | 0.0 |
5yr CAGR Net Profit
|
-18.9 % | n/a | -28.89 % |
5yr Average Return on Assets
|
3.55 % | -4.13 % | -8.72 % |
Shareholdings
|
|||
Promoter Holding
|
28.74 % | 27.89 % | 42.98 % |
Share Pledged by Promoters
|
0.0 | 0.0 | 0.0 |
Change in Promoter Holding (3 Yrs)
|
0.0 | 0.0 | 0.0 |
Change in Mutual Fund Holding (3 Yrs)
|
0.0 | 0.0 | 0.0 |
Zenith Health Care
|
Chemo Pharma Labs
|
Shamrock Indl. Co
|
|
---|---|---|---|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|